Published in Hypertens Res on December 01, 2003
Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension. Arch Med Sci (2010) 0.95
Associations between increased renal resistive index and cardiovascular events. J Med Ultrason (2001) (2015) 0.75
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res (2009) 5.24
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res (2014) 4.83
Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension (2012) 3.15
Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens (2009) 2.62
The Japanese Society of Hypertension Guidelines for Self-monitoring of Blood Pressure at Home (Second Edition). Hypertens Res (2012) 2.23
Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A (2002) 2.23
Pulmonary venous flow and risk of cardiovascular disease in essential hypertension. J Hypertens (2008) 2.05
Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol (2009) 1.95
Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation (2003) 1.86
Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J Hypertens (2005) 1.84
Treatment of acquired perforating dermatosis with narrowband ultraviolet B. J Am Acad Dermatol (2004) 1.59
Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis (2011) 1.55
Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways. Endocrinology (2004) 1.53
Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens (2006) 1.52
Pulse pressure is an independent predictor for the progression of aortic wall calcification in patients with controlled hyperlipidemia. Hypertension (2004) 1.50
Cross-sectional characterization of all classes of antihypertensives in terms of central blood pressure in Japanese hypertensive patients. Am J Hypertens (2009) 1.50
Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients. Am J Hypertens (2008) 1.46
Risk Stratification of Acute Kidney Injury Using the Blood Urea Nitrogen/Creatinine Ratio in Patients With Acute Decompensated Heart Failure. Circ J (2015) 1.46
Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol (2002) 1.45
High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Hum Mol Genet (2007) 1.44
Influence of adrenomedullin 2/intermedin gene polymorphism on blood pressure, renal function and silent cerebrovascular lesions in Japanese: the Ohasama study. Hypertens Res (2011) 1.43
Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm. Hypertens Res (2010) 1.43
Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology (2003) 1.40
Serial changes in renal function as a prognostic indicator in advanced heart failure patients with left ventricular assist system. Ann Thorac Surg (2012) 1.39
C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol (2005) 1.31
Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol (2006) 1.30
Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res (2003) 1.25
Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart. Circulation (2008) 1.23
Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita study. Hypertension (2008) 1.20
Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis (2004) 1.20
Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes (2012) 1.17
The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res (2011) 1.13
Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens (2010) 1.11
Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension. Am J Hypertens (2003) 1.09
Association of hypoadiponectinemia with smoking habit in men. Hypertension (2005) 1.08
ANRIL: molecular mechanisms and implications in human health. Int J Mol Sci (2013) 1.07
Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. Am J Hypertens (2004) 1.04
Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts. Regul Pept (2005) 1.03
TRIC-A channels in vascular smooth muscle contribute to blood pressure maintenance. Cell Metab (2011) 1.02
Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension (2005) 1.02
Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Circulation (2005) 1.02
CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. Biochem Biophys Res Commun (2012) 1.01
Effects of UV irradiation on the sebaceous gland and sebum secretion in hamsters. J Dermatol Sci (2003) 1.01
Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res (2002) 0.99
Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis (2002) 0.98
Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients. J Dermatol (2003) 0.97
Association of renal resistive index with target organ damage in essential hypertension. Am J Hypertens (2012) 0.97
Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis (2006) 0.97
Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension. Hypertens Res (2002) 0.97
[Scientific statement] Report of the Salt Reduction Committee of the Japanese Society of Hypertension (3) Assessment and application of salt intake in the management of hypertension. Hypertens Res (2013) 0.97
Natriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart. Curr Cardiol Rev (2009) 0.96
Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol (2007) 0.96
Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis. Nephrol Dial Transplant (2011) 0.96
Development of a new mouse model (xeroderma pigmentosum a-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma. J Invest Dermatol (2005) 0.95
Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides. Arterioscler Thromb Vasc Biol (2009) 0.95
Serum uric acid is an independent risk factor for cardiovascular disease and mortality in hypertensive patients. Hypertens Res (2012) 0.94
Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease. J Hypertens (2013) 0.94
Pioglitazone improves left ventricular diastolic function in patients with essential hypertension. Am J Hypertens (2005) 0.94
Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects. Drug Metab Dispos (2009) 0.94